A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRP

Clinical trial NCT07119125 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07119125
Sponsor: Monte Rosa Therapeutics, Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Elevated CRP

Start date: 2025-06-27
Primary completion: 2026-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.